bextra lawyers
801.322.2222

Bextra
Celebrex
Fosamax

ReNu
Vioxx

WinHas.com

Bextra Lawsuit

Winder & Haslam is representing Bextra users who suffered a heart attack or stroke. If you or a loved one has been injured as a result of Bextra, we encourage you to contact us for more information about your legal rights.

Bextra Recall

The FDA announced on April 7, 2005 that Bextra would be removed from the market because its risk-to-benefit profile was unfavorable. This action is the result of months of intense scrutiny into the safety of Bextra, a popular Cox-2 inhibitor, and follows six months after the withdrawal of Vioxx.

Celebrex, another Cox-2 inhibitor manufactured by Pfizer, will carry a black-box warning to warn of heart attacks and strokes. Our law firm also is representing people injured by Celebrex in lawsuits against Pfizer.

Bextra Warning

On December 23, 2004, the FDA urged doctors to limit prescribing Bextra. The FDA was concerned of recent evidence that the drug may increase the risk of heart attack and stroke. Bextra came under close scrutiny following the Vioxx recall.

Many physicians believe the problems that plagued Vioxx may also exist with Bextra. Both Bextra and Vioxx belong to a class of pharmaceuticals known as Cox-2 Inhibitors. If you or a loved one has been injured as a result of Bextra, we encourage you to learn more about the Bextra lawsuit.

Bextra Linked to Heart Attacks, Strokes

On November 10, 2004, a study conducted by the American Heart Association indicated a strong link between heart attacks and strokes. The study combined data from 5,930 patients participating in 12 separate trials. The results showed that patients given Bextra were at a 2.19 times greater risk of suffering a heart attack or stroke.

Pfizer disclosed on October 15 that high-risk heart patients taking Bextra were at an elevated risk of suffering significant cardiovascular problems. The manufacturer added a warning to this effect on the labeling for Bextra. Bextra now carries a black box warning, the most serious of warnings appearing on pharmaceuticals.

Stevens Johnson Syndrome

Bextra also is linked to a potentially fatal skin condition known as Stevens Johnson Syndrome. Symptoms of the disease include skin rash, blistering, fever, cough, and swelling.

Bextra and Your Health

If you are currently taking Bextra, you should meet with your physician to discuss alternatives. You should not stop using the medication unless your doctor instructs you to do so.


For more information about the Bextra warning and details on the lawsuit, please complete our convenient online contact form.

 
Bextra Recall
 
In spite of news that Bextra may be attributed to increased risk of heart attack and stroke, Pfizer has resisted issuing a Bextra recall. The FDA has not yet required a withdrawal of Bextra, although the agency has encouraged doctors to avoid prescribing Bextra. The FDA reports that it is analyzing data from recent clinical studies to determine whether a recall is appropriate.
Bextra News

FDA Urges Limiting Use of Pfizer's Bextra
Reuters
December 23, 2004

FDA Urges Doctors to Limit Prescriptions for Bextra
The New York Times
December 24, 2004

Bextra Heart Risks Similar to Vioxx
MSNBC
November 10, 2004

Contact Winder & Haslam
Name
Phone
Email